Search

Your search keyword '"Yadav, Ghanshyam"' showing total 281 results

Search Constraints

Start Over You searched for: Author "Yadav, Ghanshyam" Remove constraint Author: "Yadav, Ghanshyam"
281 results on '"Yadav, Ghanshyam"'

Search Results

2. Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

3. Ichthyosis uteri: A keratinizing squamous metaplasia of the endometrium with premalignant potential

5. Evaluating the Sum of Eye and Motor Components of the Glasgow Coma Score As a Predictor of Extubation Failure in Patients With Acute Brain Injury

11. Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-injured patients: a secondary analysis of the ENIO study

13. Collaborative Filtering Based Personalized Hybrid Recommendation System Using Machine Learning Techniques.

15. Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitor

16. PI3K oncogenic mutations mediate resistance to afatinib in HER2/neu overexpressing gynecological cancers

18. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma

20. Supplementary Figure 1 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

21. Data from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

22. Supplementary Table 1 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

23. Supplementary Figure 3 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

24. Supplementary Figure 2 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

25. Supplementary Table 2 from In Vitro and In Vivo Activity of IMGN853, an Antibody–Drug Conjugate Targeting Folate Receptor Alpha Linked to DM4, in Biologically Aggressive Endometrial Cancers

26. Figure S2 from Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

27. Table S1 from Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer

31. Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response

34. Extubation in neurocritical care patients: the ENIO international prospective study

35. Susceptibility profile of blaOXA-23 and metallo-β-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations.

36. Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu

42. Applying Human-Centered Design Principles to Digital Syndromic Surveillance at a Mass Gathering in India: Viewpoint

47. Duloxetine in Reducing Catheter-Related Bladder Discomfort: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study.

50. Comparison of Efficacy of Combination Therapy with Chlorpromazine and Olanzapine with Chlorpromazine alone for Treatment of Hiccups in Traumatic Brain Injury Patients-A Randomised Control Trial.

Catalog

Books, media, physical & digital resources